Monday, March 30, 2026

Trulieve Reports Q1 Revenues of $96.1 Million, Net Income of $14.0 Million

Trulieve Cannabis (CSE: TRUL) reported its first quarter 2020 financial results this morning, posting revenues of $96.1 million for the period ended March 31, 2020, while posting a net income of $14.0 million.

Revenues were a significant quarter over quarter improvement from the firms fourth quarter, rising 21% while gross margins were up 30%. Trulieve reported a gross margin of $67.1 million before fair value adjustments for the quarter. However, operating expenses grew by 21%, showing that they are relatively consistent when compared to that of revenues, with expenses coming in at $28.3 million, as compared to $23.4 million in the prior quarter.

Total expenses came in at $31.5 million, with the company pulling out depreciation and amortization from operating expenses. Sales and marketing was the largest expense at $22.0 million, followed by general and administrative at $6.3 million. After interest expenses of $6.9 million and other income of $4.9 million, the company reported a net income of $14.0 million after taxes.

Looking at the balance sheet, the firm saw an improvement in its cash position, reporting $100.8 million in the bank as compared to $91.8 million in the prior quarter. Inventories grew to $227.9 million from $204.45 million, while biological assets fell from $66.7 million to $41.3 million. Trulieve’s total current assets climbed to $384.5 million from $369.9 million over the three month period.

On the current liabilities side, the largest quarter over quarter increase was that of income tax payable, which grew from $12.2 million to $30.7 million. Accounts payable climbed to $25.9 million from $24.3 million. Total current liabilities overall grew from $56.7 million to $73.6 million.

Trulieve Cannabis last traded at $18.55 on the CSE.


Information for this briefing was found via Sedar, Canaccord Genuity and Trulieve Cannabis Corp. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why the Market May Be Misreading Iran | David Woo

Why US Fertilizer Supply Could Matter a Lot More Now | Pat Varas – Sage Potash

Roscan Gold: Mali Discount Hits Kandiole PEA

Recommended

Antimony Resources Expands New Discovery Following Trenching

Silver47 Kicks Off 7,000-Meter Drill Campaign at Nevada’s Hughes Project

Related News

Trulieve Q4 2023 Financials: 4% Revenue Drop, Narrowed Losses

Trulieve Cannabis (CSE: TRUL) has released its financial results for the fourth quarter and full...

Thursday, February 29, 2024, 02:05:05 PM

Trulieve Loses Foreign Private Issuer Status, Must Transition To US GAAP Reporting Standards

Evidently, recent buying activity in Trulieve Cannabis Corp (CSE: TRUL) has come largely from South...

Tuesday, July 14, 2020, 09:16:53 AM

Canaccord Raises Trulieve Price Target To $75 From $60

The last two weeks have been quite an enjoyable time for U.S cannabis sector investors....

Wednesday, January 13, 2021, 02:53:00 PM

Trulieve Sees Q3 Revenues Fall Slightly To $275 Million, Cash Flow Improves

Trulieve Cannabis (CSE: TRUL) reported a mixed bag of results this morning for its third...

Thursday, November 9, 2023, 08:30:31 AM

Harvest Moon: Did Trulieve Overpay For Its Pennsylvania Entrance?

Recently, Trulieve Cannabis (CSE: TRUL) announced that it would be entering the state of Pennsylvania...

Sunday, September 27, 2020, 11:46:00 AM